期刊文献+

聚乙二醇干扰素-α-2a 和替比夫定治疗乙型肝炎 e 抗原阳性慢性乙型肝炎急性发作患者的疗效比较 被引量:2

原文传递
导出
摘要 在 HBV 感染的自然史中,肝炎的急性发作频繁发生,在HBeAg 阳性 CHB 患者尤其常见。肝炎急性发作与强烈的免疫反应、广泛的肝细胞溶解有关,严重时可导致肝功能失代偿和肝功能衰竭[1]。2009年美国肝病研究学会修订的CHB 的临床指南把 CHB 急性发作定义为短时间内 ALT 升高超过10×正常值上限(upper limit of normal,ULN)或2倍的基线值[2]。
出处 《中华传染病杂志》 CAS CSCD 北大核心 2015年第5期294-296,共3页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献2

二级参考文献15

共引文献832

同被引文献27

  • 1Antonio Facciorusso,Annabianca Amoruso,Viviana Neve,Matteo Antonino,Valentina Del Prete,Michele Barone.WJH 6^(th) Anniversary Special Issues(4): Cirrhosis Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis[J].World Journal of Hepatology,2014,6(11):793-799. 被引量:4
  • 2Moucari R, Korevaar A, Lada O, et al. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study[J]. J Hepatol, 2009,50(6) : 1084-1092. DOI: 10. 1016/j. jhep. 2009. 01. 016.
  • 3Buster EH, Hansen BE, Lau GK,et al. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa [J]. Gastroenterology, 2009, 137(6) :2002-2009. DOI: 10. 1053/j. gastro. 2009.08. 061.
  • 4Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management [J]. J Hepatol, 2014,61(6) : 1407-1417. DOI: 10. 1016/i. jhep. 2014. 08.033.
  • 5Lok AS, McMahon BJ. Chronic hepatitis B: update 2009[J]. Hepatology, 2009,50(3) :661-662. DOI: 10. 1002/hep. 23190.
  • 6Fried MW, Piratvisuth T, Lau GK,et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B [J]. Hepatology, 2008,47 (2) : 428-434. DOI: 10. 1002/hep. 22065.
  • 7Yuen MF, Yuan HJ, Hui CK, et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection~ implications for antiviral therapy [J]. Gut, 2003,52(3), 416-419. DOI:10. 1136/gut. 52.3. 416.
  • 8Cai Q, Chen F, Shao X, et al. Treatment of pegylated interferon- a2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation [J]. Antivir Thor, 2015,20(2) : 217-224. DOI: 10. 3851/IMP2832.
  • 9Chen CC, Wang PC, Chang HW, etal. Safety and efficacy of two-step peginterferon a-2a treatment in patients of chronic hepatitis B with acute exacerbation [J]. J Viral Hepat, 2012, 19(3) :161-172. DOI:10. 1111/j. lg65-2893. 2011. 01469. x.
  • 10Wursthorn K, Lutgehetmann M, Dandri M, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B [J]. Hepatology, 2006,44(3) :675-684. DOI: 10. 1002/hep. 21282.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部